| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/AJT.12162 |
| P698 | PubMed publication ID | 23414257 |
| P50 | author | Kathryn Tinckam | Q41279089 |
| P2093 | author name string | H J Ross | |
| S Chih | |||
| P2860 | cites work | Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action | Q46681755 |
| Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy | Q34238488 | ||
| Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. | Q34994108 | ||
| Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection | Q36317528 | ||
| Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review | Q36797961 | ||
| A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy | Q37044200 | ||
| Report from a consensus conference on antibody-mediated rejection in heart transplantation | Q37313051 | ||
| Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. | Q37313068 | ||
| Current and future challenges in therapy for antibody-mediated rejection | Q37862862 | ||
| The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). | Q37873625 | ||
| A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. | Q39116909 | ||
| Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation | Q43546998 | ||
| Pre- and posttransplantation allosensitization in heart allograft recipients: Major impact of de novo alloantibody production on allograft survival | Q44081261 | ||
| Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. | Q46060462 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 1069-1074 | |
| P577 | publication date | 2013-02-15 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | A survey of current practice for antibody-mediated rejection in heart transplantation. | |
| P478 | volume | 13 |
| Q94476124 | Antibody-mediated rejection after lung transplantation |
| Q88013655 | Antithymocyte Globuline Therapy and Bradycardia in Children |
| Q48215946 | C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients. |
| Q38927773 | Canadian Society of Transplantation Members' Views on Anonymity in Organ Donation and Transplantation |
| Q56366608 | Complications of Cardiac Transplantation |
| Q34048065 | Donor selection in heart transplantation |
| Q51634522 | Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts. |
| Q30276550 | Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue |
| Q27006030 | Late and chronic antibody-mediated rejection: main barrier to long term graft survival |
| Q38674466 | Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation |
| Q92616025 | Recommendations for Therapeutic Apheresis by the Section "Preparative and Therapeutic Hemapheresis" of the German Society for Transfusion Medicine and Immunohematology |
| Q51359156 | Safety and Efficacy of Immunoadsorption in Heart Transplantation Program. |
| Q88656410 | The Approach to Antibodies After Heart Transplantation |
| Q38793606 | The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions |
| Q56963763 | The clinical impact of donor-specific antibodies in heart transplantation |
| Q38217127 | Therapeutic plasma exchange rapidly improves cardiac allograft function in patients with presumed antibody-mediated rejection |
| Q102319264 | Urgent therapeutic plasma exchange |
Search more.